These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Expert consensus on clinical diagnosis and treatment of portal hypertension with hepatocellular carcinoma (2022)]. Chinese Society of Spleen and Portal Hypertension Surgery, Chinese Society of Surgery, Chinese Medical Association Zhonghua Wai Ke Za Zhi; 2022 Apr; 60(4):310-320. PubMed ID: 35272421 [TBL] [Abstract][Full Text] [Related]
6. Non-transplant therapies for patients with hepatocellular carcinoma and Child-Pugh-Turcotte class B cirrhosis. Granito A; Bolondi L Lancet Oncol; 2017 Feb; 18(2):e101-e112. PubMed ID: 28214411 [TBL] [Abstract][Full Text] [Related]
7. Multidisciplinary treatment of patients with hepatocellular carcinoma. Masaki T; Morishita A; Kurokohchi K; Kuriyama S Expert Rev Anticancer Ther; 2006 Oct; 6(10):1377-84. PubMed ID: 17069523 [TBL] [Abstract][Full Text] [Related]
8. Application of adoptive cell therapy in hepatocellular carcinoma. Wu D; Li Y Immunology; 2023 Dec; 170(4):453-469. PubMed ID: 37435926 [TBL] [Abstract][Full Text] [Related]
9. Extracellular Vesicles, A Possible Theranostic Platform Strategy for Hepatocellular Carcinoma-An Overview. D'Agnano I; Berardi AC Cancers (Basel); 2020 Jan; 12(2):. PubMed ID: 31973229 [TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma: diagnosis and treatment. Befeler AS; Di Bisceglie AM Gastroenterology; 2002 May; 122(6):1609-19. PubMed ID: 12016426 [TBL] [Abstract][Full Text] [Related]
11. Atezolizumab and Bevacizumab Combination Therapy in the Treatment of Advanced Hepatocellular Cancer. Ventura I; Sanchiz L; Legidos-García ME; Murillo-Llorente MT; Pérez-Bermejo M Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201624 [TBL] [Abstract][Full Text] [Related]
12. Is survival for hepatocellular carcinoma increasing? A population-based study on survival of hepatocellular carcinoma patients in the 1990s and 2000s. Raffetti E; Portolani N; Molfino S; Mentasti S; Baiocchi GL; Magoni M; Donato F Clin Res Hepatol Gastroenterol; 2021 Jan; 45(1):101433. PubMed ID: 32409284 [TBL] [Abstract][Full Text] [Related]
13. An overview of loco-regional treatments in patients and mouse models for hepatocellular carcinoma. Bimonte S; Barbieri A; Palaia R; Leongito M; Albino V; Piccirillo M; Arra C; Izzo F Infect Agent Cancer; 2015; 10():9. PubMed ID: 25755676 [TBL] [Abstract][Full Text] [Related]
15. Compound Kushen injection combined with transarterial chemoembolization for hepatocellular carcinoma: An evidence map and overview of systematic reviews. Lu T; Kong B; Wang Y; Yu J; Pan Y; Chen D; Li H; Chen X; Yuan Z; Yang Z; Zhang J; Ding T; Zhang G; Fan Q; Wang X J Ethnopharmacol; 2024 Jan; 319(Pt 3):117267. PubMed ID: 37838291 [TBL] [Abstract][Full Text] [Related]
16. Percutaneous ablation for small hepatocellular carcinoma. Yin XY; Lu MD Expert Rev Gastroenterol Hepatol; 2009 Apr; 3(2):121-30. PubMed ID: 19351283 [TBL] [Abstract][Full Text] [Related]
18. [Research and application of Wang W; You J Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2017 Jun; 34(3):480-484. PubMed ID: 29745518 [TBL] [Abstract][Full Text] [Related]
19. [Multidisciplinary experts consensus on diagnosis and treatment of precancerous lesions of hepatocellular carcinoma (2023 version)]. ; Zhonghua Gan Zang Bing Za Zhi; 2023 Dec; 31(12):1250-1261. PubMed ID: 38253068 [TBL] [Abstract][Full Text] [Related]